Corona acquires Myoril brand from Sanofi Healthcare India for Rs 234 crore

With the Myoril brand becoming a part of its portfolio, CORONA gains its first offering in the muscle relaxant category, strengthening its existing line up of more than 80 brands. The scientific expertise and market presence of Myoril in the muscle relaxant market complement Corona’s therapeutic enrichment efforts and strengthen its orthopaedic portfolio.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/Zq5JVxa
via